The guidelines exist. The evidence is clear. So why does the gap between what we know and what we do in practice persist? In this Industry Innovations episode, guest host Daniel E. Soffer, MD, MNLA sits down with Nihar R. Desai, MD, MPH, FNLA and Jessica M. Pena, MD, MPH, FNLA to tackle one of the most pressing challenges in cardiovascular medicine: implementation.
Together, this trio of experts shares their perspectives on the real-world barriers to translating the 2026 dyslipidemia guidelines into everyday clinical practice. This candid conversation touches on where the field stands today, what they hope to see change, and what the future of ASCVD management looks like.
This episode’s topic comes courtesy of Amgen, a member of the NLA Industry Council.
